Biologic for the treatment of high risk b cell acute lymphoblastic leukemia

Ended Cooperative Agreement Awarded Last action

Award ID
R43CA224723
Recipient
Awarding agency
Obligated
$349,999

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Originally
Place of performance
Loma Linda, CA 92354, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment ELF zone - innovation corp administrative supplement $50,000
Original award $299,999

Quick answers

Who received award R43CA224723?

R43CA224723 was awarded to Elf Zone Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2017.

How much is award R43CA224723 worth?

$349,999 has been obligated on R43CA224723.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award